256 related articles for article (PubMed ID: 18024433)
41. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).
Newman DK; Hamilton C; Newman PJ
Blood; 2001 Apr; 97(8):2351-7. PubMed ID: 11290597
[TBL] [Abstract][Full Text] [Related]
42. CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation.
Sieger N; Fleischer SJ; Mei HE; Reiter K; Shock A; Burmester GR; Daridon C; Dörner T
Arthritis Rheum; 2013 Mar; 65(3):770-9. PubMed ID: 23233360
[TBL] [Abstract][Full Text] [Related]
43. Src homology region 2 domain-containing phosphatase 1 positively regulates B cell receptor-induced apoptosis by modulating association of B cell linker protein with Nck and activation of c-Jun NH2-terminal kinase.
Mizuno K; Tagawa Y; Mitomo K; Watanabe N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2002 Jul; 169(2):778-86. PubMed ID: 12097380
[TBL] [Abstract][Full Text] [Related]
44. CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade.
Tuscano JM; Riva A; Toscano SN; Tedder TF; Kehrl JH
Blood; 1999 Aug; 94(4):1382-92. PubMed ID: 10438726
[TBL] [Abstract][Full Text] [Related]
45. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation.
Adachi T; Flaswinkel H; Yakura H; Reth M; Tsubata T
J Immunol; 1998 May; 160(10):4662-5. PubMed ID: 9590210
[TBL] [Abstract][Full Text] [Related]
46. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
47. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
48. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
[TBL] [Abstract][Full Text] [Related]
49. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
[TBL] [Abstract][Full Text] [Related]
50. CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells.
Sathish JG; Walters J; Luo JC; Johnson KG; Leroy FG; Brennan P; Kim KP; Gygi SP; Neel BG; Matthews RJ
J Biol Chem; 2004 Nov; 279(46):47783-91. PubMed ID: 15364920
[TBL] [Abstract][Full Text] [Related]
51. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
Chan VW; Lowell CA; DeFranco AL
Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
[TBL] [Abstract][Full Text] [Related]
52. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.
Nishizumi H; Horikawa K; Mlinaric-Rascan I; Yamamoto T
J Exp Med; 1998 Apr; 187(8):1343-8. PubMed ID: 9547345
[TBL] [Abstract][Full Text] [Related]
53. Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22.
Yohannan J; Wienands J; Coggeshall KM; Justement LB
J Biol Chem; 1999 Jun; 274(26):18769-76. PubMed ID: 10373493
[TBL] [Abstract][Full Text] [Related]
54. The role of CD22 and other inhibitory co-receptors in B-cell activation.
Nitschke L
Curr Opin Immunol; 2005 Jun; 17(3):290-7. PubMed ID: 15886119
[TBL] [Abstract][Full Text] [Related]
55. The inhibitory coreceptor CD22 restores B cell signaling by developmentally regulating
Akatsu C; Alborzian Deh Sheikh A; Matsubara N; Takematsu H; Schweizer A; Abdu-Allah HHM; Tedder TF; Nitschke L; Ishida H; Tsubata T
Sci Signal; 2022 Mar; 15(723):eabf9570. PubMed ID: 35230871
[TBL] [Abstract][Full Text] [Related]
56. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
57. Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.
Chang CH; Wang Y; Gupta P; Goldenberg DM
MAbs; 2015; 7(1):199-211. PubMed ID: 25484043
[TBL] [Abstract][Full Text] [Related]
58. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.
Tuscano J; Engel P; Tedder TF; Kehrl JH
Blood; 1996 Jun; 87(11):4723-30. PubMed ID: 8639842
[TBL] [Abstract][Full Text] [Related]
59. CD72 negatively regulates signaling through the antigen receptor of B cells.
Adachi T; Wakabayashi C; Nakayama T; Yakura H; Tsubata T
J Immunol; 2000 Feb; 164(3):1223-9. PubMed ID: 10640734
[TBL] [Abstract][Full Text] [Related]
60. The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.
John B; Herrin BR; Raman C; Wang YN; Bobbitt KR; Brody BA; Justement LB
J Immunol; 2003 Apr; 170(7):3534-43. PubMed ID: 12646615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
